Study Shows Tethering Together Type 2 Diabetes Drugs Increases Efficacy of Combination Therapy
September 25th 2020Researchers at Duke University have found that the efficacy of a 2-pronged type 2 diabetes (T2D) treatment increases when the drugs are linked by a heat-sensitive tether rather than simply being concurrently administered, according to a press release.
Read More
FDA Gives Fast Track Designation for Gastric, Gastroesophageal Junction Adenocarcinoma Treatment
September 25th 2020The FDA has granted fast track designation to DKN-01 for the treatment of patients with gastric and gastroesophageal junction adenocarcinoma whose tumors have high DKK1 expression.
Read More
Medication Management Module Offers Enhanced Solution for Pharmacies, Health Plans
September 24th 2020The Medication Management Module is a solution for pharmacists to assess each patient’s medication and ensure it is appropriate, effective, and safe given the patient’s comorbidities and medication plan.
Read More
Study: Certain Immunosuppressing Drugs Do Not Increase Risk for Contracting COVID-19
September 23rd 2020A recent study found that patients on immunosuppressive therapy for common skin and rheumatic diseases, such as psoriasis and rheumatoid arthritis, are not at an increased risk for contracting COVID-19.
Read More
Community Pharmacy Foundation Is Looking for That Next Great Idea
September 23rd 2020Pharmacy Times® interviewed Anne Marie Kondic, PharmD, the executive director of the Community Pharmacy Foundation, on the grant opportunities on the horizon that support the practice of pharmacy in the community setting.
Watch
Monday Pharmaceutical Mystery: What Is Causing an Outbreak of Parkinson Disease in Young People?
September 22nd 2020Seven cases of young people with stiffness throughout their body and an inability to speak presented to hospitals in different cities throughout the country, with seemingly no link between them.
Read More